Mavromati Maria
Service d'endocrinologie, diabétologie, nutrition et éducation thérapeutique du patient, HUG, 1211 Genève 14.
Rev Med Suisse. 2021 Jan 13;17(720-1):24-28.
Health care of gender-incongruent persons deserves optimization. The new World Health Organization ICD-11, introduced this year, classifies gender-incongruence to « conditions related to sexual health », and not anymore to « mental and behavioral disorders ». From an endocrine perspective, gender-affirming hormonal treatment induces physical changes consistent with gender identity, but good-quality, long follow-up studies concerning efficacy and safety are needed. Improvements in training of medical professionals as well as a specialized multidisciplinary approach are important measures to be taken.
性别不一致者的医疗保健值得优化。今年推出的世界卫生组织新版《国际疾病分类第11版》（ICD - 11）将性别不一致归类为“与性健康相关的状况”，而非再归类为“精神和行为障碍”。从内分泌学角度来看，性别肯定激素治疗会引发与性别认同相符的身体变化，但仍需要高质量、长期的随访研究来探讨其疗效和安全性。改善医学专业人员的培训以及采用专门的多学科方法是需要采取的重要措施。
